Cited by 191vaccines and immunoinformatics approachesProtein Structure and DynamicsSARS-CoV-2 and COVID-19 Research

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Open access
Sesterhenn, Fabian, Yang, Che, Bonet, Jaume, Cramer, Johannes T., Wen, Xiaolin, Wang, Yimeng, Chiang, Chi-I, Abriata, Luciano A. +24 more·2020·Science

Abstract

TopoBuilding precision vaccines: To induce strong and targeted neutralizing antibody (nAb) responses against vaccine targets, one strategy has been to use computationally designed immunogens. However, the structural complexity of many known neutralization epitopes has posed a major challenge for the design of accurate epitope mimetics. Sesterhenn et al. created a protein design algorithm called TopoBuilder to design scaffolds for irregular and discontinuous neutralization epitopes. As a proof of principle, the authors generated epitope-focused immunogens based on the prefusion conformation of the respiratory syncytial virus (RSV) fusion protein. When these immunogens were used to vaccinate mice and nonhuman primates in RSV infection models, they generated targeted nAb responses to RSV and boosted site-specific nAb responses in heterologous prime-boost vaccination schemes. Science , this issue p. eaay5051

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aay5051

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An in silico benchmark test comprising 25 motif-scaffolding design problems addressed in six recent publications was established to evaluate motif-scaffolding methods.

    “we established an in silico benchmark test (Supplementary Table 9) comprising 25 motif-scaffolding design problems addressed in six recent publications encompassing several design methodologies4,5,29,38–40”
  • With the exception of helical bundles, previous methods do not extend readily to more complex functional sites composed of three or more chain segments.

    “Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”

    From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]

  • Previous methods can scaffold functional sites made up of one or two contiguous chain segments.

    “Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”

    From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]

  • The backbones generated by previous functional-site scaffolding methods are not guaranteed to be designable.

    “Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”

    From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sesterhenn, F., Yang, C., Bonet, J., Cramer, J. T., Wen, X., Wang, Y., Chiang, C.-I., Abriata, L. A., Kucharska, I., Castoro, G., Vollers, S. S., Galloux, M., Dheilly, E., Rosset, S., Corthésy, P., Georgeon, S., Villard, M., Richard, C.-A., Descamps, D., Delgado, T., Oricchio, E., Rameix-Welti, M.-A., Más, V., Ervin, S., Eléouët, J.-F., Riffault, S., Bates, J. T., Julien, J.-P., Li, Y., Jardetzky, T., Krey, T., & Correia, B. E.
Affiliations
  • SIB Swiss Institute of Bioinformatics (CH)
  • Medizinische Hochschule Hannover (DE)
  • Stanford Medicine (US)
  • Institute for Bioscience and Biotechnology Research (US)
  • University of Toronto (CA)
  • Université de Versailles Saint-Quentin-en-Yvelines (FR)
  • École Polytechnique Fédérale de Lausanne (CH)
  • Instituto de Salud Carlos III (ES)
  • UMR1173, INSERM, Université de Versailles St. Quentin, 78180 Montigny le Bretonneux, France.
  • Atrium Health Wake Forest Baptist (US)
  • University of Mississippi Medical Center (US)
  • University of Maryland, Baltimore (US)
Corresponding author
  • Sesterhenn, Fabian
  • Yang, Che
  • Bonet, Jaume
  • Cramer, Johannes T.
  • Correia, Bruno E.
Venue
Science
Published
2020-05-15
Volume
368
Issue
6492
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3024848554
Cited by
191
References
85
Citations by year
2026: 19 · 2025: 20 · 2024: 30 · 2023: 26 · 2022: 35 · 2021: 44 · 2020: 17
FWCI
9.90
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
  • RePEc: Research Papers in Economics (submittedVersion)
  • HAL (submittedVersion, other-oa)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion)
Funders
  • European Research Council (716058)
  • Swiss National Science Foundation (310030_163139)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
de novo protein design, respiratory syncytial virus, neutralizing antibodies, vaccine design, non-human primates, therapeutic antibodies
MeSH terms
Humans, Protein Conformation, Recombinant Fusion Proteins, Protein Engineering, Immunodominant Epitopes, Respiratory Syncytial Virus, Human, Computational Biology, Amino Acid Motifs, Respiratory Syncytial Virus Vaccines, Antibodies, Neutralizing, Single-Domain Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review